Drug resistance mechanisms identified in most common form of melanoma

Researchers have found that melanoma patients whose cancers are caused by mutation of the BRAF gene become resistant to a promising targeted treatment through another genetic mutation or the overexpression of a cell surface protein, both driving survival of the cancer and accounting for relapse. The study could result in the development of new targeted therapies to fight resistance once the patient stops responding and the cancer begins to grow again.

Read the whole article on Science Daily

More from Science Daily